Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 October 2007 18 October 2007 Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use, 15-18 October 2007Reference Number: EMEA/479200/2007 English (EN) (42.06 KB - PDF)First published: 18/10/2007 Last updated: 18/10/2007 View Related information Questions and answers on the recommendation to withdraw the marketing authorisations for Clobutinol-containing medicinesReference Number: EMEA/471052/2007 English (EN) (45.52 KB - PDF)First published: 18/10/2007 Last updated: 18/10/2007 View Questions and answers on the benefits and risks of rosiglitazone and pioglitazoneReference Number: EMEA/484464/2007 English (EN) (48.22 KB - PDF)First published: 18/10/2007 Last updated: 18/10/2007 View Questions and answers on the recommendation to suspend the marketing authorisations for carisoprodol-containing medicinesAdopted Reference Number: EMEA/520140/2007 English (EN) (41.94 KB - PDF)First published: 15/11/2007 Last updated: 15/11/2007 View Contact point Martin Harvey Allchurch or Monika BenstetterTel. (44-20) 74 18 84 27E-mail press@ema.europa.eu Share this page